chronic myelogenous leukemia-chronic phase 白血病慢性期
chronic stabilized phase 慢性稳定期
Chronic Progress Phase 慢性进展期
Methods This retrospective study involved 121 CML patients including 90 in chronic phase,8 in accelerated phase and 23 with blast crisis.
方法 121例CML患者包括:慢性期90例、加速期8例、急变期23例。
参考来源 - HLA配型对慢性粒细胞白血病异基因造血干细胞移植效果的分析·2,447,543篇论文数据,部分数据来源于NoteExpress
Conclusion The combination regimen of HHT and Ara cis effective and economical in patient with late chronic-phase chronic myelogenous leukemia(CML).
结论高三尖杉酯碱联合低剂量阿糖胞苷治疗慢粒白血病急变简便,经济,有效。
A team of researchers from the U. s. and Europe, including the drug's creator, Brian Druker, MD, followed 454 patients with chronic-phase CML taking imatinib for more than six years.
包括药物的发明者Brian Druker博士在内的一个由来自美国和欧洲的研究人员组成的团队跟踪研究了454位慢性粒细胞性白血病慢性期患者,这些患者使用伊马替尼已经超过6年。
In its second phase the company had positive results when testing their device for chronic rhinosinusitis with polyposis, chronic rhinosinusitis without polyposis and migraine therapies.
在第二个阶段的测试中公司得到了积极的结果,特别是在鼻窦炎和鼻息肉,慢性鼻窦炎和偏头痛等慢性病的治疗方面。
应用推荐